Vivo Capital

Vivo Capital

Created using Figma
Created using Figma
Vivo Capital ICO Founded in 1996, Vivo Capital is a medical investment company that invests in high-quality companies in the United States and China and focuses on building it. Vivo has adopted its own multifaceted strategy to identify and cooperate with promising developmental and therapeutic drugs in the United States and companies in China's revenue stage over management costs of more than $ 1.7 billion I will. Vivo Capital has offices in Palo Alto, California, Shanghai, Beijing, China. Vivo Capital uses its internal expertise to evaluate data and creates excess returns for investors as well as founders and employees. Vivo mainly invests in the US in the development stage of pharmaceutical and medical equipment companies in the late stage and invests in medical institutions in China at the earnings stage.
Ico
Oct 16, 2018
Dec 31, 2018
100% completed
Raised funds - no Data
past
Pre Ico
Oct 1, 2018
Oct 15, 2018
100% completed
Raised funds - no Data
past
Token Details
Accepted Currencies
ETH
Company Details
Registered Country
United States
Additional Details
MVP/Prototype
Yes
KYC
Yes
Categories
Platform

About Vivo Capital

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China.

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

Vivo Capital Roadmap

  • Q1 2018

  • • Generating the idea.
    • Evaluating the market and development potential.
    • Market Research.
  • Q2 2018

  • • Launching the development.
    • Expanding the team.
    • Developing the company's legal structure.
  • Q3 2018

  • • Preparing for the ICO.
    • Whitepaper
    • Landing page
    • Performing Private Sale
    • Bounty & AirDrop
  • Q4 2018

  • • Performing the Pre-sale.
    • Performing ICO Main sale.
    • Bounty & AirDrop Distribution.
  • Read More
  • Q1 2019

  • • Exchange Listing Process starts.
    • Mobile application testing
    • Establishing Representative Office
  • Q2 2019

  • • Launch the Platform in Full mode
    • Mobile application release
  • Q3 2019

  • • Marketing
    • Licensing and entering the Asian market.
  • Q4 2019

  • • Obtaining the payment licenses.
    • Completion of developing the platform core.

Activity

Activity:
103
MEDIUM
Posts:
107
LOW
Views:
946
VERY LOW
Activity:
103
MEDIUM
Merit:
0
VERY LOW
Posts:
195
LOW
Views:
2 513
LOW
Users:
74
LOW
Posts:
44
VERY LOW
Followers:
207
VERY LOW
Likes:
204
VERY LOW
Rating:
5
VERY HIGH
Members:
948
LOW
30 Days Growth:
66
Alexa

Rank:
14 715 239
VERY LOW
Delta:
5 129 528
Year commits:
2
Watchers:
0
Stars:
0
Forks:
0
Open issues:
0

Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Lawrence Wang
Managing Director
unverified
Michael Chang
Managing Director
unverified
Jack Bech Nielsen
Managing Director
unverified
Gaurav Aggarwal
Managing Director
unverified
Frank Kung
Managing Partner
unverified
Albert Cha
Managing Partner
unverified
Shan Fu
Managing Partner
unverified
Chen Yu
Managing Partner
unverified
Derek Yang
Finance Director
unverified
Peiyi Zhao
Head of Legal
unverified
Albert Chang
Managing Partner
unverified
Edgar G. Engleman
Managing Partner
unverified
Mahendra G. Shah
Managing Director
unverified
Hwachie Lee
Managing Director
unverified
Jo Shen
Venture Partner
unverified
Yuh-geng Tsay
Venture Partner
unverified
Tracy Wu
General Director
unverified
Joseph Siletto
Managing Director
unverified
Daisy Xu
General Director
unverified
Nathan Dau
Associate
unverified
Eric Trac
Associate
unverified
Tiantian Zhu
Analyst
unverified
Ethan Zhao
Associate
unverified
Tierney Y. Li
Analyst
unverified
Andrew D. Goldberg
Principal
unverified
Vinayak Nikam
Associate
unverified
Adrianne Chang
Consultant
unverified
Dan Dan Dong
Principal
unverified
Qi Zhu
Principal
unverified
Nina Feng
Principal
unverified
Kevin Dai
Principal
unverified
David Liu
Principal
unverified
Daniel Qin
Associate
unverified
Lingfei Zhao
Analyst
unverified
Sue Shao
Associate
unverified
Yixuan Li
Analyst
unverified
Waika Cheng
Analyst
unverified
Aaron Royston
Senior Associate
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Ronghuan Lin
Advisor
unverified

Last News

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO